Drug class in one race

CB1 receptor drugs for Obesity

5 tracked CB1 receptor drugs in the Obesity race. The class explanation lives on the CB1 receptor page; the full indication pipeline across every mechanism is on the Obesity page.

2 Phase 23 Phase 1

Head-to-head evidence: CRB-913 vs INV-202 · CRB-913 vs monlunabant · INV-202 vs INV-347 · INV-202 vs monlunabant · INV-202 vs nimacimab · INV-347 vs monlunabant

The roster

← all CB1 receptor drugs